SOLIGENIX, INC. current report, 17 September 2026

SOLIGENIX, INC. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on September 17, 2026, specifically the Company's 2026 Annual Meeting of Stockholders. Soligenix, Inc. is a Delaware corporation with its principal executive offices in Princeton, NJ, and its common stock trades on The Nasdaq Capital Market under the symbol SNGX.

Key Financial Metrics

This filing is a current report regarding corporate governance and capital structure events. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing references a prior capital raise under an At Market Issuance Sales Agreement where approximately $6,234,000 of shares were sold, and a recent increase to the offering amount of $2,500,000.

Material Changes and Corporate Actions

  • Charter Amendment (Authorized Shares): Stockholders approved an amendment to increase the number of authorized shares of Common Stock from 75,000,000 to 125,000,000. This became effective upon filing with the Delaware Secretary of State on September 17, 2026.
  • Reverse Stock Split Authorization: Stockholders approved a proposal granting the Board of Directors discretion to effect a reverse stock split at a ratio of 1-for-2 to 1-for-20 for a period of up to one year.
  • Capital Markets Activity: On June 26, 2026, the Company filed a prospectus supplement to increase the maximum aggregate offering amount under its Sales Agreement with Rodman & Renshaw LLC by an additional $2,500,000.

Voting Results and Governance

Seven proposals were voted upon at the Annual Meeting:

  • Election of Directors: All five nominees (Christopher J. Schaber, Gregg A. Lapointe, Diane L. Parks, Robert J. Rubin, and Jerome B. Zeldis) were elected. Significant broker non-votes (7,470,895) were recorded.
  • Executive Compensation: The advisory vote on executive compensation was approved. Stockholders selected a 1-year frequency for future advisory votes on compensation.
  • Auditor Ratification: The appointment of Cherry Bekaert LLP as the independent registered public accounting firm for the year ending December 31, 2026, was ratified.
  • Adjournment: The proposal to adjourn the meeting if necessary to solicit further proxies was approved.

Investor Verification Checklist

  • Verify the effective date and filing status of the Charter Amendment with the Delaware Secretary of State.
  • Monitor future Board announcements regarding the specific ratio and timing of the authorized reverse stock split.
  • Review the updated At Market Issuance Sales Agreement terms following the $2.5 million increase in the offering cap.
  • Confirm the total number of outstanding shares post-approval of the authorized share increase.